Skip to main content
Premium Trial:

Request an Annual Quote

Mayo Clinic Laboratories, Helix Collaborate to Offer Biopharma Lab Services

NEW YORK – Mayo Clinic Laboratories and Helix announced on Tuesday a strategic collaboration to provide laboratory research and development services to biopharma customers.

The offering includes Mayo Clinic Laboratories' portfolio of over 3,800 tests and pathology services and Helix's Exome+ next-generation sequencing assay.

The partnership builds upon the Tapestry study, an ongoing clinical genomics study of the impact of genetic testing on an individual's short- and long-term healthcare that is sponsored by both the Mayo Clinic Center for Individualized Medicine and Helix and launched in 2020.

"By pairing Helix’s innovative Exome+ assay with Mayo's world-class clinical and diagnostic testing knowledge, this collaboration will allow biopharma companies to access molecular and nonmolecular testing services needed across the drug development process," said Mayo Clinic Laboratories CEO William Morice II in a statement.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.